Cyclin D1 expression in squamous cell carcinomas of the head and neck and in oral mucosa in relation to proliferation and apoptosis

Clinical Cancer Research

Volumn 3, Issue 1, 1997, Pages 95-101

  Kotelnikov, Valery M ^a   Coon IV, John S ^b   Mundle, Suneel ^a   Kelanic, Stephen ^b   LaFollette, Suzanne ^a   Taylor IV, Samuel ^a   Hutchinson, James ^b   Panje, William ^b   Caldarelli, David D ^b   Preisler, Harvey D ^a  

^a RUSH CANCER INSTITUTE   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; CYCLINE;

APOPTOSIS; ARTICLE; CELL CYCLE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOLOGY; DNA SYNTHESIS; GENE EXPRESSION; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MOUTH CANCER; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CELL DIVISION; CYCLIN D1; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; MOUTH MUCOSA; MOUTH NEOPLASMS; TISSUE DISTRIBUTION;

EID: 0031058809     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Strauss, M., Lukas. J., and Bartek, J. Unrestricted cell cycle and cancer. Nat. Med., 1: 1245-1246, 1995.
2. Pardee, A. B. G1 events and regulation of cell proliferation. Science (Washington DC), 246: 603-608, 1989.
3. Sherr, C. J. Mammalian G1 cyclins. Cell, 73: 1059-1065, 1994.
4. Schuuring, E., Verhoeven, E., Mooi, W. J., and Michalides, R. J. A. M. Identification and cloning of two overexpressed genes, U21B31/ PRAD1 and EMS1, within the amplified chromosome 11q13 region in human carcinomas. Oncogene, 7: 355-361, 1992.
5. Bartkova, J., Lukas, J., Strauss, M., and Bartek, J. Cyclin D1 onco-protein aberrantly accumulates in malignancies of diverse histogenesis. Oncogene, 10: 775-778, 1995.
6. Motokura, T., Bloom, T., Kim, H. G., Juppner, H., Ruderman, J. V., Kronenberg, H. M., and Arnold, A. A novel cyclin encoded by a bcl-linked candidate oncogene. Nature (Lond.), 350: 512-515, 1991.
7. Withers, H. D., Harvey, R. C., Faust, J. B., Melnik, O., Carey, K., and Meeker, T. C. Characterization of candidate bcl-1 gene. Mol. Cell Biol., 4: 1133-1144, 1991.
8. Berenson, J. R., Yang, J., and Mickel, R. A. Frequent amplification of the bcl-1 locus in head and neck squamous cell carcinomas. Oncogene, 4: 1111-1116, 1989.
9. Somers, K. D., Cartwright, S. L., and Schechter, G. L. Amplification of int-2 gene in human head and neck squamous cell carcinomas. Oncogene, 5: 915-920, 1990.
10. Callender, T., El-Naggar, A. K., Lee, M. S., Frankenthaler, R., Luna, M. A., and Batsakis, J. G. PRAD-1 (CCND1)/cyclin D1 oncogene amplification in primary head and neck squamous cell carcinoma. Cancer (Phila.), 74: 152-158, 1994.
11. Bellacosa, A., Almadori, G., Cavallo, S., Cadoni, G., Galli, J., Ferrandina, G., Scambia, G., and Neri, G. Cyclin D1 gene amplification in human laryngeal cell carcinomas: prognostic significance and clinical implications. Clin. Cancer Res., 2: 175-180, 1996.
12. 1 regulation in human head and neck cancer. Cancer Res., 55: 949-956, 1995.
13. Michalides, R., van Veelen, N., Hart, A., Loftus, B., Wientjens, E., and Balm, A. Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck. Cancer Res., 55: 975-978, 1995.
14. Gillett, C., Fantl, V., Smith, R., Fisher, C., Bartek, J., Dickson, C., Barnes, D., and Peters, G. Amplification and overexpression of cyclin D] in breast cancer detected by immunohistochemical staining. Cancer Res., 54: 1812-1817, 1994.
15. Zukerberg, L. R., Yang, W-I., Gadd, M., Thor, A. D., Koerner, F. C., Schmidt, E. V., and Arnold, A. Cyclin D1 (PRAD1) protein expression in breast cancer: approximately one-third of infiltrating mammary carcinomas show overexpression of the cyclin D1 oncogene. Mod. Pathol., 8: 560-567, 1995.
16. Lovec, H., Sewing, A., Lucibello, F. C., Muller, R., and Moroy, T. Oncogenic activity of cyclin D1 revealed through cooperation with Ha-ras: link between cell cycle control and malignant transformation. Oncogene, 9: 323-326, 1994.
17. Lovec, H., Grzeschiczek, A., and Moroy, T. Cyclin D1/bcl-1 cooperates with myc genes in the generation of B-cell lymphoma in transgenic mice. EMBO J., 13: 3487-3495, 1994.
18. Wang, T. C., Cardiff, R. D., Zukerberg, L., Lees, E., Arnold, A., and Schmidt, E. V. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature (Lond.), 369: 669-671, 1994.
19. Afar, D. F., McLaughlin, J., Sherr, C. J., Witte, O. N., and Roussel, M. F. Signaling by ABL oncogene through cyclin D1. Proc. Natl. Acad. Sci. USA, 92: 9540-9544, 1995.
20. Dulic, V., Drullinger, L. F., Lee, E., Reed, S. I., and Stein, G. H. Altered regulation of G1 cyclins in senescent human fibroblasts: accumulation of inactive cyclin E-cdk2 and cyclin D1 -cdk2 complexes. Proc. Natl. Acad. Sci. USA, 90: 11034-11038, 1993.
21. Atadja, P., Wong, H., Veilette, C., and Riabowol, K. Overexpression of cyclin D1 blocks proliferation of normal diploid fibroblasts. Exp. Cell Res., 217: 205-216, 1995.
22. Freeman, R. S., Estus, S., and Johnson, E. M. Analysis of cell cycle-related gene expression in postmitotic neurons: selective induction of cyclin D1 during programmed cell death. Neuron, 12: 343-355, 1994.
23. Bennett, M., Wilson, G., Dische, S., Saunders, M., Martindale, C., Robinson, B., O'Halloran, A., Leslie, M., and Laing, J. Tumor proliferation assessed by combined histological and flow cytometrical analysis: implications for therapy in squamous cell carcinoma in the head and neck. Br. J. Cancer, 65: 870-878, 1992.
24. Foster, G., Cooke, T., Cooke, L., Stanton, P., Bowie, G., and Stell, P. Tumor growth rates in squamous carcinoma of the head and neck measured by in vivo bromodeoxyuridine incorporation and flow cytometry. Br. J. Cancer. 65: 698-702, 1992.
25. Kotelnikov, V. M., Coon, J., Haleem, A., Taylor, S., Hutchinson, J., Panje, W., Caldarelli, D., and Preisler, H. D. Cell kinetics of head and neck cancers. Clin. Cancer Res., 1: 527-537, 1995.
26. Begg, A., Hofland, I., Van Glabekke, M., Bartelink, H., and Horiot, G. Predictive value of potential doubling time for radiotherapy of head and neck patients: results from the EORTC Cooperative trial 22851. Semin. Radiat. Oncol., 2: 22-25, 1992.
27. Corvo, R., Giaretti, W., Sanguineti, G., Geido, E., Orecchia, R., Guenzi, M., Margarino, G., Bacigalupo, A., Garaventa, G., Barbieri, M., and Vitale, V. In vivo cell kinetics in head and neck squamous cell carcinomas predicts local control and helps guide radiotherapy regimen. J. Clin. Oncol., 13: 1843-1850, 1995.
28. Tomasino, R. M., Daniele, E., Bazan, V., Morello, V., Tralongo, V., Nuara, R., Nagar, C., Salvato, M., Ingria, F., Restivo, S., Dardanoni, G., Vecchione, A., and Russo, A. Prognostic significance of cell kinetics in laryngeal squamous cell carcinoma: clinicopathological associations. Cancer Res., 55: 6103-6108, 1995.
29. England, M. C., and Burke, G. W. Autoradiographic demonstration of DNA synthesis in selected epithelial tissues in male rats. J. Dent. Res., 48: 1219-1223, 1969.
30. Raza, A., Maheshwari, Y., and Preisler, H. Differences in cell cycle characteristics amongst patients with acute non-lymphocytic leukemia. Blood, 69: 1647-1650, 1987.
31. Mundle, S., Iftikhar, A., Shetty, V., Alvi, S., Dameron, S., Gregory, S., Marcus, B., Khan, S., and Raza, A. In situ end-labeling of DNA to detect apoptotic cell death in a variety of human tumors. Cell Death & Differ., 1: 117-122, 1994.
32. Bartkova, J., Lukas, J., Muller, H., Lutzhoft, D., Strauss, M., and Bartek, J. Cyclin D1 protein expression and function in human breast cancer. Int. J. Cancer, 57: 353-361, 1994.
33. Weinstat-Saslow, D., Merino, M. J., Manrow, R. E., Lawrence, J. A., Bluth, R. F., Wittenbel, K. D., Simpson, J. F., Page, D. L., and Steeg, P. S. Overexpression of cyclin D mRNA distinguishes invasive and in situ breast carcinomas from non-malignant lesions. Nat. Med., 1: 1257-1260, 1995.
34. Weinberg, R. A. The retinoblastoma protein and cell cycle control. Cell, 81: 323-330, 1995.
35. Maestro, R., Piccinin, S., Doglioni, C., Gasparotto, D., Vukosavljevic, T., Sulfaro, T, Barzan, L., and Boiocchi, M. Chromosome 13q deletion mapping in head and neck squamous cell carcinomas: identification of two distinct regions of preferential loss. Cancer Res., 56: 1146-1150, 1996.
36. Han, E., Begenman, M., Sgambato, A., Son, J. W., Xing, W-Q., and Weinstein, I. B. Increased expression of cyclin D1 in a murine mammary epithelial cell line inhibits growth and enhances apoptosis. Proc. Am. Assoc. Cancer Res., 37: 8, 1996.
37. Shimamura, A., and Fisher, D. E. p53 in life and death. Clin. Cancer Res., 2: 435-440, 1996.
38. Vaux, D. L., and Strasser, A. The molecular biology of apoptosis, Proc. Natl. Acad. Sci. USA, 93: 2239-2244, 1996.
39. El-Diery, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., and Vogelstein, B. WAF1, a potential mediator of p53 tumor suppression. Cell. 75: 817-825, 1993.
40. Chen, X., Bargonetti, J., and Prives, C. p53, through p21 (WAF1/ CIP1), induces cyclin D1 synthesis. Cancer Res., 55: 4257-4263. 1995.
41. Daksis, J. I., Lu, R. Y., Facchini, L. M., Marhin, W. W., and Penn, L. J. Z. Myc induces cyclin D1 expression in the absence of de novo protein synthesis and links mitogen-stimulated signal transduction to the cell cycle. Oncogene, 9: 3635-3645, 1994.
42. Steiner, P., Philipp, A., Lukas, J., Godden-Kent, D., Pagano, M., Mittnacht, S., Bartek, J., and Eilers, M. Identification of a Myc-dependent step during the formation of active G1 cyclin-cdk complexes. EMBO J., 14: -4814-4826, 1995.
43. Evan, G. I., Wyllie, A. H., Gilbert, C. S., Littlewood, T. D., Land, H., Brooks, M., Waters, C. M., Penn, L. Z., and Hancock, D. C. Induction of apoptosis in fibroblasts by c-myc protein. Cell, 69; 119-129, 1992.
44. Hermeking, H., and Eick, D. Mediation of c-MYC-induced apoptosis by p53, Science (Washington DC), 265: 2091-2093, 1994.
45. Sherr, C. J., Matsushime, H., and Roussel, M. Regulation of CYL/cyclin D genes by colony-stimulating factor 1. CIBA Found. Sympos., 170: 209-219, 1992.
46. Slaughter, D. L., Southwick, H. W., and Smeical, W. "Field cancerization" in oral stratified squamous epithelium: clinical implications of multicentric origin. Cancer (Phila.), 6: 963-968, 1953.
47. Strong, M. S., Incze, J., and Vaughan, C. V. Field cancerization in aerodigestive tract: its etiology, manifestation, and significance. J. Otolaryngol., 110: 45-54, 1984.
48. Kotelnikov, V. M., Coon, J., Taylor, S., Hutchinson, J., Panje, W., Caldarelli, D., LaFollette, S., and Preisler, H. D. In vivo labeling with halogenated pyrimidines of squamous cell carcinomas and adjacent non-involved mucosa of head and neck region. Cell Proliferation, 28: 497-509, 1995.
49. Kotelnikov, V. M., Coon, J., Taylor, S., Hutchinson, J., Panje, W., Caldarelli, D., LaFollette, S., and Preisler, H. D. Proliferation of epithelia of non-involved mucosa in patients with head and neck cancer. Head & Neck, 18: 522-528, 1996.